Lundbeck
HLUN-B.CO
#2505
Rank
S$7.79 B
Marketcap
$8.14
Share price
-0.93%
Change (1 day)
18.53%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2024 (TTM): S$0.63 Billion

According to Lundbeck 's latest financial reports the company's current earnings are S$2.98 Billion. In 2023 the company made an earning of S$0.58 Billion, an increase over its 2022 earnings that were of S$0.48 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$0.63 B8.31%
2023 S$0.58 B21.69%
2022 S$0.48 B31.79%
2021 S$0.36 B-4.53%
2020 S$0.38 B-45.08%
2019 S$0.69 B-33.97%
2018 S$1.05 B12.76%
2017 S$0.93 B94.32%
2016 S$0.48 B-136.98%
2015 -S$1.31 Billion-1258.1%
2014 S$0.11 B-72.43%
2013 S$0.40 B4.31%
2012 S$0.39 B-55.26%
2011 S$0.87 B6.64%
2010 S$0.81 B-6.68%
2009 S$0.87 B